ANGO
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- AngioDynamics received FDA IDE approval for the RELIEF feasibility study evaluating NanoKnife IRE for benign prostatic hyperplasiaJun 17, 2026
- AngioDynamics expanded access to NanoKnife IRE for prostate and liver cancer under new Medicare coverageMay 29, 2026
- AngioDynamics enrolls first patient in AMBITION BTK trial to advance treatment for critical limb ischemiaJul 28, 2025
- AngioDynamics enrolls first patient in RECOVER-AV trial evaluating AlphaVac F1885 System for acute pulmonary embolismJun 23, 2025